18 nov: Scor 400.000 på din pension
19 nov: Den vildeste Porsche
19-11-2010 10:37:27

AstraZeneca confirms eyeing Astra Tech spin-off

Relateret indhold

LONDON (Reuters) - AstraZeneca (Astrazeneca PLC ORD SHS $0.25) confirmed on Friday it was considering spinning off its Astra Tech dental implants and medical devices business and had hired JP Morgan Chase (JP Morgan Chase & Co) to help with a strategic review of the unit.

A source familiar with the situation said earlier this week that the Anglo-Swedish drugmaker was looking to sell the non-core Swedish-based business for some $2 billion (1.2 billion pounds) after hiring the bank as adviser.

"AstraZeneca continues to evaluate all alternatives for value maximisation from this business and any final decision will only be made when the results of the review have concluded," the company said in a brief statement.

A company spokeswoman confirmed that a sale of the operation was one option. She declined to comment on the timing of any decision.

The expected sale of Astra Tech highlights AstraZeneca's current focus on boosting returns as the group heads into a wave of patent expiries on some of its biggest-selling medicines.

In contrast to some of its rivals -- such as GlaxoSmithKline (Glaxosmithkline PLC ORD 25P), Novartis and Sanofi-Aventis -- AstraZeneca has stayed focussed on its core pharmaceuticals business rather than seeking diversification.

Shares in the company were barely changed by 9:30 a.m., down 0.3 percent at 3053.5 pence, in line with a flat Stoxx 600 European healthcare sector index .

The Astra Tech business could be of interest to U.S. companies such as privately held Biomet, Medtronic (Medtronic plc Ordinary Shares), 3M (3M Company), Danaher (Danaher Corporation) and Dentsply International (Dentsply Sirona Inc Common St), as well as private equity firms, according to industry analysts.

Companies operating in the sector in Europe include Swiss dental implant firms Nobel Biocare and Straumann .

Astra Tech, best known for dental implants, also sells urological catheters, breathing aids and blood management systems used in surgery. It has 2,200 employees worldwide and produced revenue in 2009 of $506 million, AstraZeneca said.

(Reporting by Ben Hirschler; Editing by Greg Mahlich)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aktier/Spar Nord: Chr. Hansen junis bedste aktie målt på afkast

30-06-2016 15:58:28
Juni har i den grad været præget af det britiske EU-valg, der har skabt store udsving på aktiemarkederne. Brexit betyder, at C20-indekset ser ud til at afslutt..

Mærsk/SHB: Salg af Oil mere sandsynligt efter tabt kontrakt

30-06-2016 14:01:39
Det er i langt højere grad blevet en mulighed, at A.P. Møller–Mærsk skærer sit olieben fra, efter at Maersk Oil er blevet fravalgt som partner på oliefeltet Al ..

Siemens skal betale erstatning til syge medarbejdere - NY

30-06-2016 11:22:11
Vindmøllefabrikken Siemens Wind er ved Retten i Aalborg blevet dømt til at betale knap en million kroner i erstatning til tre medarbejdere, der blev syge af arb..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Dansk kornkæmpe solgt for milliardbeløb - citat
2
Vestas vinder ordre på 76 MW i Sverige - Google er modtager -NY
3
Aktier/tendens: Udsigt til små fald på aktiemarkedet
4
Genmab/Sydbank: Positivt med canadisk Darzalex-godkendelse
5
Deutsche Bank dykker efter at have dumpet i amerikansk test

Relaterede aktiekurser

JP Morgan Chase & Co 62,14 1,5% Stigning i aktiekurs
Danaher Corporation 101,00 0,9% Stigning i aktiekurs
3M Company 175,12 2,1% Stigning i aktiekurs
Dentsply Sirona Inc Comm.. 62,04 0,9% Stigning i aktiekurs
Straumann N 383,75 0,0% Aktiekurs uændret
Astrazeneca PLC ORD SHS .. 4.332,12 -3,0% Fald i aktiekurs
Glaxosmithkline PLC ORD .. 1.591,36 -0,8% Fald i aktiekurs
Medtronic plc Ordinary S.. 86,77 1,5% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
1. juli 2016 04:34:32
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160627.1 - EUROWEB7 - 2016-07-01 04:34:32 - 2016-07-01 04:34:32 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x